From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Camba-Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €137,100 and a net result of €47,651. Equity is growing by about 40% per year across the filed financial years. Its solvency ranks better than 48% of 22,679 sector peers (NACE 47, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
KBO- Status
- Active since 07-01-2019 Normal situation
- Legal form
- Private limited company
- Registered office
- Droogveldeweg 7, 9031 Gent
- Activity
- Retail sale of pharmaceutical products NACE 47730and 1 other
- Establishment unit
- 2.283.517.976 9031 Gent, since 09-01-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
How it is doing
- Gross margin
- €69,398
- ▲ 21.6%
- Turnover
- ≈ €340,000
- estimated
- Profit
- €47,651
- ▲ 28.9%
- Equity
- €137,100
- ▲ 31.3%
- Total assets
- €437,825
- ▼ 4.1%
SignalsneutralLatest accounts filed on timeShow the evidence
Checked score
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 30 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Financials · financial year 2025, micro format
Annual accounts 2025
- Financial year ended
- 31-12-2025
- Filed on
- 08-04-2026
- Format
- micro format
- Reference
- 2026-00076156
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 22% above 2024 and is the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,392 | €369 | €369 | €369 | €369 | €369 | €369 | = |
| Other operating charges640/8 | - | - | €120 | €122 | €132 | €141 | €144 | ▲ 2.6% |
| Gross operating margin9900 | €6,711 | €31,635 | €33,234 | €50,436 | €49,374 | €57,060 | €69,398 | ▲ 21.6% |
| Operating profit (loss)9901 | €5,320 | €31,266 | €32,745 | €49,945 | €48,873 | €56,550 | €68,885 | ▲ 21.8% |
| Financial income75/76B | - | - | €133 | €643 | €3 | €82 | €2 | ▼ 97.6% |
| Recurring financial income75 | €0 | - | €133 | €643 | €3 | €82 | €2 | ▼ 97.6% |
| Financial charges65/66B | - | - | €2,826 | €5,004 | €5,247 | €5,756 | €4,646 | ▼ 19.3% |
| Recurring financial charges65 | €415 | €2,816 | €2,826 | €5,004 | €5,247 | €5,756 | €4,646 | ▼ 19.3% |
| Profit (loss) for the period before taxes9903 | €4,904 | €28,450 | €30,052 | €45,585 | €43,629 | €50,877 | €64,241 | ▲ 26.3% |
| Income taxes67/77 | €2,184 | €8,565 | €9,812 | €13,744 | €11,576 | €13,922 | €16,590 | ▲ 19.2% |
| Profit (loss) for the period9904 | €2,720 | €19,885 | €20,240 | €31,841 | €32,054 | €36,955 | €47,651 | ▲ 28.9% |
| Profit (loss) for the period to be appropriated9905 | €2,720 | €19,885 | €20,240 | €31,841 | €32,054 | €36,955 | €47,651 | ▲ 28.9% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €15,493 | €244,805 | €265,702 | €458,890 | €457,640 | €456,352 | €437,825 | ▼ 4.1% |
| Fixed assets21/28 | €3,323 | €217,954 | €217,585 | €432,215 | €431,846 | €431,477 | €431,108 | ▼ 0.1% |
| Tangible fixed assets22/27 | €3,323 | €2,954 | €2,585 | €2,215 | €1,846 | €1,477 | €1,108 | ▼ 25.0% |
| Furniture and vehicles24 | - | - | €2,585 | €2,215 | €1,846 | €1,477 | €1,108 | ▼ 25.0% |
| Financial fixed assets28 | - | €215,000 | €215,000 | €430,000 | €430,000 | €430,000 | €430,000 | = |
| Current assets29/58 | €12,170 | €26,851 | €48,117 | €26,675 | €25,794 | €24,875 | €6,717 | ▼ 73.0% |
| Amounts receivable within one year40/41 | €7,287 | €15,175 | €26,153 | €21,856 | €11,322 | €19,264 | - | - |
| Trade receivables40 | - | - | €6,397 | €21,856 | €10,783 | €19,264 | - | - |
| Other amounts receivable41 | - | - | €19,756 | - | €538 | - | - | - |
| Cash at bank and in hand54/58 | €4,042 | €11,209 | €20,848 | €3,901 | €14,216 | €5,527 | €6,440 | ▲ 16.5% |
| Deferred charges and accrued income490/1 | - | - | €1,116 | €918 | €257 | €85 | €277 | ▲ 227% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €15,493 | €244,805 | €265,702 | €458,890 | €457,640 | €456,352 | €437,825 | ▼ 4.1% |
| Equity10/15 | €8,108 | €27,193 | €59,833 | €50,441 | €67,494 | €104,449 | €137,100 | ▲ 31.3% |
| Contributions10/11 | €6,200 | - | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €1,908 | €20,993 | €41,233 | €31,841 | €48,894 | €85,849 | €118,500 | ▲ 38.0% |
| Distributable reserves133 | - | - | €41,233 | €31,841 | €48,894 | €85,849 | €118,500 | ▲ 38.0% |
| Amounts payable17/49 | €7,385 | €217,611 | €205,869 | €408,449 | €390,145 | €351,903 | €300,724 | ▼ 14.5% |
| Amounts payable after more than one year17 | - | €180,107 | €163,482 | €327,634 | €289,809 | €251,488 | €212,664 | ▼ 15.4% |
| Financial debts170/4 | - | - | €163,482 | €327,634 | €289,809 | €251,488 | €212,664 | ▼ 15.4% |
| Amounts payable within one year42/48 | €6,900 | €37,224 | €42,155 | €80,253 | €99,813 | €93,336 | €87,271 | ▼ 6.5% |
| Current portion of amounts payable after more than one year42 | - | - | €18,000 | €40,424 | €40,955 | €41,492 | €42,037 | ▲ 1.3% |
| Financial debts43 | - | - | - | €5,853 | €2,706 | €3,884 | €4,890 | ▲ 25.9% |
| Other loans439 | - | - | - | €5,853 | €2,706 | €3,884 | €4,890 | ▲ 25.9% |
| Trade debts44 | €2,217 | €1,618 | €189 | €996 | €373 | €321 | €8,850 | ▲ 28× |
| Suppliers440/4 | - | - | €189 | €996 | €373 | €321 | €8,850 | ▲ 28× |
| Advances received on contracts in progress46 | - | - | - | - | - | €22,385 | - | - |
| Taxes, remuneration and social security45 | - | - | €23,897 | €23,255 | €18,799 | €7,686 | €11,626 | ▲ 51.3% |
| Taxes450/3 | - | - | €23,897 | €19,727 | €13,255 | €7,686 | €11,626 | ▲ 51.3% |
| Remuneration and social security454/9 | - | - | - | €3,528 | €5,544 | - | - | - |
| Other amounts payable47/48 | - | - | €69 | €9,726 | €36,981 | €17,568 | €19,868 | ▲ 13.1% |
| Accrued charges and deferred income492/3 | - | - | €232 | €562 | €523 | €7,078 | €790 | ▼ 88.8% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €2,720 | €19,885 | €20,240 | €31,841 | €32,054 | €36,955 | €47,651 | ▲ 28.9% |
| + Depreciation and write-downs630 | €1,392 | €369 | €369 | €369 | €369 | €369 | €369 | = |
| Operating cash flow (approximation) | €4,112 | €20,254 | €20,609 | €32,210 | €32,423 | €37,324 | €48,020 | ▲ 28.7% |
| Investment in fixed assets (approximation) | - | -€215,000 | €0 | -€215,000 | €0 | €0 | €0 | - |
| Change in cash | - | €7,167 | €9,639 | -€16,947 | €10,315 | -€8,689 | €913 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (7)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 08-04-2026 | 2026-00076156 | |
| 31-12-2024 | micro format | 18-07-2025 | 2025-00295780 | |
| 31-12-2023 | micro format | 19-07-2024 | 2024-00270143 | |
| 31-12-2022 | micro format | 02-07-2023 | 2023-00199051 | |
| 31-12-2021 | micro format | 05-07-2022 | 2022-20150759 | |
| 31-12-2020 | micro format | 15-06-2021 | 2021-20300459 | |
| 31-12-2019 | micro format | 31-08-2020 | 2020-48900346 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Camille BAETSLÉ |
|
How the board is organised
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Bestuursorgaan, met of zonder beperking”3 more provisions on this in the deed
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding, aandeelhouders”“Besluit algemene vergadering in vormen statutenwijziging”1 more provision on this in the deed
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Alle schulden naar evenredigheid zonder onderscheid opeisbaar en niet-opeisbaar onder aftrek disconto, opeisbare eerst op eigen risico…”
Articles of association, deed of 29-12-2023
Owners and capital
Capital and shareholders
- 29-12-2023 Converted to unavailable equity · €18,600
Shares according to the articles of association
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Overdracht geheel of gedeelte aandelen onder levenden, enige aandeelhouder alleen”
- Other provisionsRules from the articles on subjects other than the board, the shares, the purpose and the meetings.
- Other provision: “Aandelen moeten bij uitgifte worden volgestort, stortingsplicht aandelen”Other provision: “Beraadslaging-aanwezigheidsquorum, wettelijke en statutaire bepalingen aandelen zonder stemrecht”Other provision: “Controle, schadevergoeding”Other provision: “Winstverdeling en uitkeringen, algemene vergadering op voorstel bestuursorgaan”Liquidation distribution: “Aandeelhouders a rato aandelenbezit, blote eigenaars met last plaatsing op geblokkeerde bankrekening op naam blote eigenaars en…”Other provision: “Dag verdeling aandelen of aflevering legaten, overlijden enige aandeelhouder met erf-gerechtigden”12 more provisions in the deed, see the deed of 29-12-2023
Articles of association, deed of 29-12-2023 (in Dutch)
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
50%
Connections & network
1 current directorThe board mandates are listed below; here you explore them as a network.
Board mandates elsewhere
1 board mandateHistory
Acts, filings and financial milestones
29-12
Gazette deed
Resignation: Camille BAETSLÉ (director)Appointment: Camille BAETSLÉ (director) · Amendment of the articles · Capital conversion9 facts ▸
- General meeting, 21-12-2023
- Amendment of the articles (2 times)
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Capital
- Power of attorney, Jessica Verhaeghe
- Director resignation, Camille BAETSLÉ (director)
- Director appointment, Camille BAETSLÉ (director (not named in the articles))
- Director discharge, Camille BAETSLÉ
- Registered office clause, “Droogveldeweg 7, zevende besluit algemene vergadering” (deed in Dutch)
03-01
Gazette deed
Registered office · Legal-form changeRegistered-office move2 facts ▸
- Board meeting, 01-09-2022
- Registered-office move, Droogveldeweg 7,9031 Drongen
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
Register details
Who it is
KBO recordWhere it is based
What it does
NACEBEL 2025Invoicing and payment
Financial year and general meeting
Accounts at the NBBScores and ratios are computed by Checked and are not a credit decision.
Purpose, financial year and meetings according to the articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het verlenen van alle mogelijk advies en managementondersteuning voor de algemene uitbating van een apotheek; Het verlenen van…”
18 activities
- Het verlenen van alle mogelijk advies en managementondersteuning voor de algemene uitbating van een apotheek
- Het verlenen van dienstprestaties van economische aard in de farmaceutische sector,zowel in eigen beheer als in deelname met derden,daartoe behoren technoconsult,assistentie op gebied van management,engineering en consulting,technisch,commercieel,administratief en financieel beheer en advies,alsook het ter beschikking stellen en verhuren van dienstdoend apotheker en/of apotheekassistent(en)
- Het maken van alle farmaceutische,farmacologische en toxicologische studies en onderzoeken betreffende alle commerciële en industriële activiteiten,de organisatie van vennootschappen en ondernemingen,het verrichten van marktonderzoek,de promotie en het raad geven met betrekking tot industriële en commerciële projecten en alle werkzaamheden met betrekking tot de informatica
- De studie,verkoop en fabricage van voedingssupplementen,kruiden,sportproducten
- De invoer,de uitvoer,doorvoer,opslag en verkoop van bovenvermelde producten,evenals van grondstoffen en de moederlogen bestemd voor de bereiding van deze producten,alsook van planten,gewassen en etherische oliën,zonder dat deze opsomming beperkend weze
- De invoer,uitvoer,doorvoer,opslag en verkoop van alcolholhoudende dranken en van verscheidene fantasieartikelen,gecatalogeerd onder de benaming gadgets,zonder dat deze opsomming beperkend weze
- Het drukken en verspreiden van geschriften,studies en werken over bovenvermelde producten,en hun leer,fungeren als raadgevend bureau inzake industriële en commerciële activiteit die betrekking hebben op therapeutische middelen in hun meest uitgebreide toepassing
- Het beheren,het verwerven,de instandhouding en het valoriseren van een onroerend vermogen,de huurfinanciering van onroerende goederen aan derden,alsmede alle handelingen die rechtstreeks of onrechtstreeks met dit doel in verband staan en die van aard zijn de opbrengst van de onroerende goederen te bevorderen,zoals het onderhoud,de ontwikkeling,de verfraaiing en de verhuring van deze goederen,alsmede zich borg stellen voor het goede verloop van verbintenissen door derde personen aangegaan die het genot zouden hebben van deze onroerende goederen
- Het verwerven,hetzij door inschrijving of aankoop van aandelen,obligaties,kasbons of andere roerende waarden,van welke vorm ook,van Belgische of buitenlandse bestaande of nog op te richten vennootschappen alsook het beheer van deze roerende waarden,dit alles enkel voor eigen rekening
- Het ontwikkelen,kopen,verkopen,beheer,in waarde stellen,in licentie nemen of geven van brevetten,octrooien,know-how en andere intellectuele rechten
- De aan-en verkoop,in-en uitvoer,commissiehandel en vertegenwoordiging van om het even welke goederen,in’t kort tussenpersoon in de handel
- Alle verrichtingen van commerciële,industriële,onroerende,roerende of financiële aard die rechtstreeks of onrechtstreeks met haar voorwerp verwant of verknocht zijn of de verwezenlijking ervan kunnen bevorderen
- Het uitvoeren van alle studies en onderzoek,het verrichten van marktonderzoek,promotie,raadgeving,prospectie,marketing,techno-consult,assistentie op gebied van management,engineering en consulting;technisch,commercieel,administratief,financieel,fiscaal en juridisch beheer en advies
- Het bevorderen van de oprichting van vennootschappen door inbreng,participatie of investering
- Het toestaan van leningen en kredietopeningen aan vennootschappen of particulieren onder om het even welke vorm;in dit kader kan zij zich ook borg stellen of haar aval verlenen,in de meest ruime zin,alle handels-en financiële operaties verrichten behalve die welke wettelijk voorbehouden zijn aan depositobanken,houders van deposito's op korte termijn,spaarbanken,hypotheekmaatschappijen en kapitalisatieondernemingen
- Alle verrichtingen en diensten,hetzij als makelaar,agent of welk danige hoedanigheid,inzake verzekeringen en herverzekeringen van alle aard,zowel voor natuurlijke als voor rechtspersonen
- Het optreden als tussenpersoon bij onderhandelingen voor gehele of gedeeltelijke overname van aandelen;in de meest ruime betekenis,het deelnemen aan emissieverrichtingen van aandelen en vastrentende waarden door intekening,waarborgplaatsing,verhandeling of anderszins,alsmede het verwezenlijken van om het even welke verrichtingen inzake portefeuille-of kapitaalsbestuur
- Het waarnemen van alle bestuursopdrachten in andere vennootschappen,het uitoefenen van mandaten en functies in alle ondernemingen
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- CAMBA-PHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest”
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- In June at 20:00
Articles of association, deed of 29-12-2023 (in Dutch)
Environmental permits: No permit applications found in Flanders.
Sites & property
1 establishment unit
Buildings and parcels at the address
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 44017C0131/00F000 | Flanders | 856 m² | 1 · 156 m² | 7.0 m · 2 |